Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction

被引:116
作者
Pizzato, M
Marlow, SA
Blair, ED
Takeuchi, Y
机构
[1] Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England
[2] Royal Free Hosp, Polymasc Pharmaceut PLC, London NW3 2EZ, England
[3] GlaxoWellcome, Med Res Ctr, Virol Unit, Stevenage SG1 2NY, Herts, England
基金
英国惠康基金;
关键词
D O I
10.1128/JVI.73.10.8599-8611.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The initial step of virus-cell interaction was studied by immunofluorescence microscopy. Single particles of murine leukemia virus (MLV) vectors and human immunodeficiency virus (HIV) were visualized by immunofluorescence. Fluorescent dots representing single virions could be localized by staining of capsid proteins (CA) or surface envelope proteins (SU) after fixation of virus supernatants. This technique can be used to determine particle concentration in viral supernatants and also to study virus-cell interaction. We investigated the role of the Env-receptor interaction for the initial binding event between the cell and the viral particles. Ecotropic MLV vector particles were shown to bind to human cells which do not express the specific viral receptor. In addition, MLV particles defective for Fm were shown to bind the cells similarly to infectious MLV. Time course experiments of virus-cell binding and dissociation showed identical profiles for infectious and Env-defective MW particles and suggested that MLV Env is not involved in the early phases of attachment of virus to cells. The possible implication of cellular factors in enhancing viral binding and infectivity is discussed.
引用
收藏
页码:8599 / 8611
页数:13
相关论文
共 44 条
[1]   VIRUS PARTICLE ADSORPTION .3. ADSORPTION OF VIRUSES BY CELL MONOLAYERS AND EFFECTS OF SOME VARIABLES ON ADSORPTION [J].
ALLISON, AC ;
VALENTINE, RC .
BIOCHIMICA ET BIOPHYSICA ACTA, 1960, 40 (03) :400-410
[2]   VIRUS PARTICLE ADSORPTION .2. ADSORPTION OF VACCINIA AND FOWL PLAGUE VIRUSES TO CELLS IN SUSPENSION [J].
ALLISON, AC ;
VALENTINE, RC .
BIOCHIMICA ET BIOPHYSICA ACTA, 1960, 40 (03) :393-399
[3]   Fluorescent viral vectors: A new technique for the pharmacological analysis of gene therapy [J].
Bartlett, JS ;
Samulski, RJ .
NATURE MEDICINE, 1998, 4 (05) :635-637
[4]   Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein [J].
Battini, JL ;
Rodrigues, P ;
Muller, R ;
Danos, O ;
Heard, JM .
JOURNAL OF VIROLOGY, 1996, 70 (07) :4387-4393
[5]   PROPAGATION OF RECOMBINANT VACCINIA VIRUS IN HELA-CELLS - ADSORPTION-KINETICS AND REPLICATION IN BATCH CULTURES [J].
CHILLAKURU, RA ;
RYU, DDY ;
YILMA, T .
BIOTECHNOLOGY PROGRESS, 1991, 7 (02) :85-92
[6]   Retroviral infection is limited by Brownian motion [J].
Chuck, AS ;
Clarke, MF ;
Palsson, BO .
HUMAN GENE THERAPY, 1996, 7 (13) :1527-1534
[7]   HIGH-TITER PACKAGING CELLS PRODUCING RECOMBINANT RETROVIRUSES RESISTANT TO HUMAN SERUM [J].
COSSET, FL ;
TAKEUCHI, Y ;
BATTINI, JL ;
WEISS, RA ;
COLLINS, MKL .
JOURNAL OF VIROLOGY, 1995, 69 (12) :7430-7436
[8]   RETROVIRAL RETARGETING BY ENVELOPES EXPRESSING AN N-TERMINAL BINDING DOMAIN [J].
COSSET, FL ;
MORLING, FJ ;
TAKEUCHI, Y ;
WEISS, RA ;
COLLINS, MKL ;
RUSSELL, SJ .
JOURNAL OF VIROLOGY, 1995, 69 (10) :6314-6322
[9]  
Cosset FL, 1996, GENE THER, V3, P946
[10]   A role for DNA-PK in retroviral DNA integration [J].
Daniel, R ;
Katz, RA ;
Skalka, AM .
SCIENCE, 1999, 284 (5414) :644-647